Cincinnati Enquirer: Powell's death shows importance of vaccination
UC expert discusses COVID-19 risks for multiple myeloma patients
Colin Powell, former secretary of state and chairman of the Joint Chiefs of Staff, died earlier this week of COVID-19 complications. News reports state Powell was fully vaccinated but was also receiving treatment for a blood cancer, multiple myeloma, at the time of his death. Multiple myeloma weakens the body's immune system.
Bryan Hambley, MD, assistant professor of internal medicine in the University of Cincinnati College of Medicine's Division of Hematology and Oncology and a UC Health hematology oncologist, said other multiple myeloma patients can become more fearful and socially isolated following the death of a high-profile person like Powell.
"That can really increase depression as a side effect of treatment,” Hambley told the Cincinnati Enquirer.
Powell's death also highlights the importance for friends and family of immunocompromised patients like those with multiple myeloma to be vaccinated against COVID-19 "to protect their loved ones who may not form antibodies to the vaccine," Hambley said.
Featured photo at top of vaccination courtesy of Shutterstock.com
Related Stories
UC study: Boosting brain protein levels may slow decline from...
September 11, 2024
A study led by University of Cincinnati researchers found that new monoclonal antibody drugs for Alzheimer’s may slow cognitive impairment through boosting levels of the protein Aβ42 in the brain.
Poll: Lower-income Black parents talk to kids about race...
September 10, 2024
The University of Cincinnati's Steven Kniffley spoke with Parents.com about a recent Gallup poll that found lower-income Black families with young children are more likely to discuss the challenges of race with their kids than other families.
Exit Lab helps health care innovators find commercialization...
September 10, 2024
The Exit Lab at the University of Cincinnati’s 1819 Innovation Hub helps health care entrepreneurs find ways to commercialize their products and connect with potential investors.